<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01435785</url>
  </required_header>
  <id_info>
    <org_study_id>Propofol TCI in Geriatric</org_study_id>
    <nct_id>NCT01435785</nct_id>
  </id_info>
  <brief_title>Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients</brief_title>
  <acronym>TCIGeriatric</acronym>
  <official_title>Derivation and Prospective Validation of Four Pharmacokinetic-Pharmacodynamic Models of Propofol in Elderly Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad del Desarrollo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad del Desarrollo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the wide use of propofol target-controlled infusion (TCI) in elderly patients,
      pharmacokinetic (PK) and pharmacodynamic (PD) models performance has not been prospectively
      assessed in this population. The aims of this study are to derive four PKPD models using
      previously published PK parameters sets, and to prospectively assess their performance in
      elderly people. With the obtained data we propose to build a specific PKPD model for this
      population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After BISÂ® and routine monitors were placed, 14 ASA I-II elderly patients (&gt;65 yr) will be
      anesthetized with plasma TCI of propofol based on Schnider model. After partial recovery from
      a bolus dose a remifentanil infusion was started and continued throughout surgery. All BIS
      and TCI data will be continuously record. Arterial blood samples for propofol assays were
      collected at 1, 2, 3, 5, 10, 20, 40 and 60 min post-induction, and at 0, 1, 3, 5, and 10 min
      after stopping the infusion. A three compartment effect site model linked to a Sigmoidal Emax
      PD model, will be used to fit all the data simultaneously in NONMEM. Median performance
      errors(MDPE), and median absolute performance errors(MDAPE) were calculated to measure bias
      and accuracy of each model. Comparisons between models will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">14</enrollment>
  <condition>Propofol Overdose of Undetermined Intent</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood will be centrifugated, the plasma will be frozen and all the samples where
      analysed wiht HPLC technique
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients older than 65 years, ASA 1,2 programed for elective sugery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 65 years, ASA 1,2

        Exclusion Criteria:

          -  Included less than 70% or more than 130% of ideal body weight

          -  Neurologic disorder

          -  Use of psychoactive medication, including alcohol intake during the last 48 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo O Sepulveda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinica Alemana Universidad del Desarrollo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinica Alemana de Santiago</name>
      <address>
        <city>Santiago</city>
        <zip>76534</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Alemana Santiago</name>
      <address>
        <city>Santiago</city>
        <zip>76534</zip>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2011</study_first_submitted>
  <study_first_submitted_qc>September 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2011</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad del Desarrollo</investigator_affiliation>
    <investigator_full_name>Pablo O. Sepulveda</investigator_full_name>
    <investigator_title>MD Professor</investigator_title>
  </responsible_party>
  <keyword>PKPD</keyword>
  <keyword>Propofol</keyword>
  <keyword>TCI</keyword>
  <keyword>Elderly patients</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Open TCI proyect</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

